BrMedj 1989;298:1671-3 Abstract Objective-To measure the safety and efficacy of antenatal treatment with anti-D immunoglobulin. Design-Open study with historical controls. Setting-Multicentre study in 17 hospitals in West Yorkshire. Patients-1238 Rh negative women who delivered Rh positive infants after 34 weeks in their first pregnancy in 1980-1 (group 1) and 2000 similar primigravidas from 19...

Corona Virus Disease 2019 (COVID-19) is a highly transmissible and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which erupted in Wuhan, China, has spread worldwide [1]. The objective of this study was to assess the seroprevalence SARS-CoV-2 among blood donors Republic Congo. Method: This an analytical cross-sectional that carried out during ...

BACKGROUND The UK guidelines for the use of anti-D immunoglobulin for rhesus prophylaxis have been revised. Anti-D immunoglobulin is no longer recommended for Rh D negative women after a threatened miscarriage less than 12 weeks gestation. These patients are at risk of rhesus immunisation, and there should be a policy for their treatment in the accident and emergency (A&E) department. DESIGN ...

or anti D, (it) anti-Rh' or antirC, and (Hi) antiRh" or anti-E. According to the latest modification in the nomenclature the designation should be anti-Rh0, anti-rh' and anti-rh".] One standard drop of each serum is put into its appropriate compartment. Then a standard drop of the rbc suspension is added. The drops are mixed with the rounded ends of glass rods. The slides are placed in the mois...

background: the assays currently available for the detection of specific anti- toxoplasma antibodies may vary in their abilities to detect serum immunoglobulins, due to the lack of a purified standardized antigen. the aim of this study was evaluation the recombinant toxoplasma gondii sag1 antigen for the serodiagnosis of acute and chronic toxoplasmosis. methods : this study describes an elisa u...

OBJECTIVE The purpose of this study was to determine the most cost-effective option to prevent alloimmunization against the Rh factor. METHODS A virtual population of Rh-negative pregnant women in Quebec was built to simulate the cost-effectiveness of preventing alloimmunization. The model considered four options: (1) systematic use of anti-D immunoglobulin; (2) fetal Rh(D) genotyping; (3) im...

Elsewhere, we reported the safety and efficacy results of a multicenter phase 3 trial of recombinant human alpha -galactosidase A (rh-alpha GalA) replacement in patients with Fabry disease. All 58 patients who were enrolled in the 20-wk phase 3 double-blind, randomized, and placebo-controlled study received subsequently 1 mg/kg of rh-alpha GalA (agalsidase beta, Fabrazyme, Genzyme Corporation) ...

Gac Méd Méx Vol. 140, Suplemento No. 3, 2004 Rh haemolytic disease of the fetus and newborn (HDN) is a condition in which the lifespan of the infant’s red cells is shortened by the binding of specific IgG Rh antibodies produced by the mother, which transfer across the placenta. The disease begins in intra-uterine life and shows a wide spectrum of severity. Not all D-positive infants born to mot...